HEADER HYDROLASE/HYDROLASE INHIBITOR 21-JUN-02 1M21 TITLE CRYSTAL STRUCTURE ANALYSIS OF THE PEPTIDE AMIDASE PAM IN COMPLEX WITH TITLE 2 THE COMPETITIVE INHIBITOR CHYMOSTATIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDE AMIDASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PAM; COMPND 5 EC: 3.5.1.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CHYMOSTATIN; COMPND 9 CHAIN: C, D; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STENOTROPHOMONAS MALTOPHILIA; SOURCE 3 ORGANISM_TAXID: 40324; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PEK06; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: STREPTOMYCES HYGROSCOPICUS, MC521-C8; SOURCE 11 ORGANISM_TAXID: 1912 KEYWDS PROTEIN-INHIBITOR COMPLEX, CORE: ELEVEN-STRANDED BETA-SHEET, COVERED: KEYWDS 2 DOUBLE LAYERS OF ALPHA HELICES ON TOP AND BOTTOM, HYDROLASE, KEYWDS 3 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.LABAHN,S.NEUMANN,G.BULDT,M.-R.KULA,J.GRANZIN REVDAT 5 16-OCT-24 1M21 1 REMARK REVDAT 4 25-OCT-23 1M21 1 SEQRES LINK REVDAT 3 13-JUL-11 1M21 1 VERSN REVDAT 2 24-FEB-09 1M21 1 VERSN REVDAT 1 16-OCT-02 1M21 0 JRNL AUTH J.LABAHN,S.NEUMANN,G.BULDT,M.-R.KULA,J.GRANZIN JRNL TITL AN ALTERNATIVE MECHANISM FOR AMIDASE SIGNATURE ENZYMES JRNL REF J.MOL.BIOL. V. 322 1053 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 12367528 JRNL DOI 10.1016/S0022-2836(02)00886-0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.NEUMANN,J.GRANZIN,M.-R.KULA,J.LABAHN REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DATA OF THE REMARK 1 TITL 2 RECOMBINANT PEPTIDE AMIDASE FROM STENOTROPHOMONAS REMARK 1 TITL 3 MALTOPHILIA REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 58 333 2002 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444901020248 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 87122 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4379 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 13762 REMARK 3 BIN R VALUE (WORKING SET) : 0.2260 REMARK 3 BIN FREE R VALUE : 0.2470 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 682 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.009 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7390 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 431 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.37000 REMARK 3 B22 (A**2) : -0.73000 REMARK 3 B33 (A**2) : 1.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.04 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.06 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.900 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.380 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.690 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.620 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 36.60 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CTC.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CTC.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1M21 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-JUN-02. REMARK 100 THE DEPOSITION ID IS D_1000016500. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUL-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : DIAMOND(111), GE(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 87122 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 60.290 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : 0.08500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.27300 REMARK 200 R SYM FOR SHELL (I) : 0.20700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1M22 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6000, HEPES, GLYCERINE, SODIUM REMARK 280 AZIDE, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.27950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: TWO BIOLOGICAL ENTITIES ARE IN THE ASYM. UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE CHYMOSTATIN A IS OLIGOPEPTIDE, A MEMBER OF ENZYME INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CHYMOSTATIN A REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 38 REMARK 465 ARG A 39 REMARK 465 ASN A 40 REMARK 465 VAL A 41 REMARK 465 PRO A 42 REMARK 465 ASP A 530 REMARK 465 THR A 531 REMARK 465 ASP A 532 REMARK 465 ALA A 533 REMARK 465 LEU A 534 REMARK 465 ILE A 535 REMARK 465 ASP A 536 REMARK 465 ALA A 537 REMARK 465 GLY A 538 REMARK 465 GLU A 539 REMARK 465 PRO A 540 REMARK 465 SER B 38 REMARK 465 ARG B 39 REMARK 465 ASN B 40 REMARK 465 VAL B 41 REMARK 465 PRO B 42 REMARK 465 ASP B 530 REMARK 465 THR B 531 REMARK 465 ASP B 532 REMARK 465 ALA B 533 REMARK 465 LEU B 534 REMARK 465 ILE B 535 REMARK 465 ASP B 536 REMARK 465 ALA B 537 REMARK 465 GLY B 538 REMARK 465 GLU B 539 REMARK 465 PRO B 540 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY A 201 C SER A 202 N 0.310 REMARK 500 PHE C 1 C PHE C 1 O -0.133 REMARK 500 PHE D 1 C PHE D 1 O -0.133 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 201 CA - C - N ANGL. DEV. = -23.1 DEGREES REMARK 500 GLY A 201 O - C - N ANGL. DEV. = 13.9 DEGREES REMARK 500 SER A 202 C - N - CA ANGL. DEV. = 31.0 DEGREES REMARK 500 SER B 202 C - N - CA ANGL. DEV. = 16.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 81 -169.76 -126.31 REMARK 500 ARG A 110 69.17 -119.08 REMARK 500 ASP A 124 21.12 -72.47 REMARK 500 ALA A 128 106.04 -160.82 REMARK 500 PHE A 173 52.89 -107.70 REMARK 500 ARG A 194 98.52 -167.89 REMARK 500 CYS A 200 -155.71 62.85 REMARK 500 SER A 203 47.83 -72.16 REMARK 500 ASP A 224 84.80 -161.47 REMARK 500 ILE A 254 -61.75 -137.20 REMARK 500 VAL A 296 86.57 -68.36 REMARK 500 THR B 81 -169.52 -126.23 REMARK 500 ARG B 110 69.24 -119.31 REMARK 500 ASP B 124 21.03 -71.71 REMARK 500 ALA B 128 106.13 -161.25 REMARK 500 PHE B 173 52.73 -108.15 REMARK 500 ARG B 194 98.62 -167.74 REMARK 500 CYS B 200 -162.51 63.74 REMARK 500 SER B 203 47.74 -80.36 REMARK 500 ASP B 224 85.06 -161.54 REMARK 500 ILE B 254 -61.41 -136.87 REMARK 500 VAL B 296 86.46 -68.42 REMARK 500 LEU C 3 46.79 37.46 REMARK 500 LEU D 3 46.93 37.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B 201 SER B 202 32.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF CHYMOSTATIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF CHYMOSTATIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1M22 RELATED DB: PDB REMARK 900 1M22 CONTAINS NATIVE PEPTIDE AMIDASE AT 1.4 A DBREF 1M21 A 38 540 UNP Q8RJN5 Q8RJN5_XANMA 38 540 DBREF 1M21 B 38 540 UNP Q8RJN5 Q8RJN5_XANMA 38 540 DBREF 1M21 C 1 4 PDB 1M21 1M21 1 4 DBREF 1M21 D 1 4 PDB 1M21 1M21 1 4 SEQRES 1 A 503 SER ARG ASN VAL PRO PHE PRO TYR ALA GLU THR ASP VAL SEQRES 2 A 503 ALA ASP LEU GLN ALA ARG MET THR ALA GLY GLU LEU ASP SEQRES 3 A 503 SER THR THR LEU THR GLN ALA TYR LEU GLN ARG ILE ALA SEQRES 4 A 503 ALA LEU ASP ARG THR GLY PRO ARG LEU ARG ALA VAL ILE SEQRES 5 A 503 GLU LEU ASN PRO ASP ALA LEU LYS GLU ALA ALA GLU ARG SEQRES 6 A 503 ASP ARG GLU ARG ARG ASP GLY ARG LEU ARG GLY PRO LEU SEQRES 7 A 503 HIS GLY ILE PRO LEU LEU LEU LYS ASP ASN ILE ASN ALA SEQRES 8 A 503 ALA PRO MET ALA THR SER ALA GLY SER LEU ALA LEU GLN SEQRES 9 A 503 GLY PHE ARG PRO ASP ASP ALA TYR LEU VAL ARG ARG LEU SEQRES 10 A 503 ARG ASP ALA GLY ALA VAL VAL LEU GLY LYS THR ASN LEU SEQRES 11 A 503 SER GLU TRP ALA ASN PHE ARG GLY ASN ASP SER ILE SER SEQRES 12 A 503 GLY TRP SER ALA ARG GLY GLY GLN THR ARG ASN PRO TYR SEQRES 13 A 503 ARG ILE SER HIS SER PRO CYS GLY SER SER SER GLY SER SEQRES 14 A 503 ALA VAL ALA VAL ALA ALA ASN LEU ALA SER VAL ALA ILE SEQRES 15 A 503 GLY THR GLU THR ASP GLY SER ILE VAL CYS PRO ALA ALA SEQRES 16 A 503 ILE ASN GLY VAL VAL GLY LEU LYS PRO THR VAL GLY LEU SEQRES 17 A 503 VAL SER ARG ASP GLY ILE ILE PRO ILE SER PHE SER GLN SEQRES 18 A 503 ASP THR ALA GLY PRO MET ALA ARG SER VAL ALA ASP ALA SEQRES 19 A 503 ALA ALA VAL LEU THR ALA ILE ALA GLY ARG ASP ASP ALA SEQRES 20 A 503 ASP PRO ALA THR ALA THR MET PRO GLY ARG ALA VAL TYR SEQRES 21 A 503 ASP TYR THR ALA ARG LEU ASP PRO GLN GLY LEU ARG GLY SEQRES 22 A 503 LYS ARG ILE GLY LEU LEU GLN THR PRO LEU LEU LYS TYR SEQRES 23 A 503 ARG GLY MET PRO PRO LEU ILE GLU GLN ALA ALA THR GLU SEQRES 24 A 503 LEU ARG ARG ALA GLY ALA VAL VAL VAL PRO VAL GLU LEU SEQRES 25 A 503 PRO ASN GLN GLY ALA TRP ALA GLU ALA GLU ARG THR LEU SEQRES 26 A 503 LEU LEU TYR GLU PHE LYS ALA GLY LEU GLU ARG TYR PHE SEQRES 27 A 503 ASN THR HIS ARG ALA PRO LEU ARG SER LEU ALA ASP LEU SEQRES 28 A 503 ILE ALA PHE ASN GLN ALA HIS SER LYS GLN GLU LEU GLY SEQRES 29 A 503 LEU PHE GLY GLN GLU LEU LEU VAL GLU ALA ASP ALA THR SEQRES 30 A 503 ALA GLY LEU ALA ASP PRO ALA TYR ILE ARG ALA ARG SER SEQRES 31 A 503 ASP ALA ARG ARG LEU ALA GLY PRO GLU GLY ILE ASP ALA SEQRES 32 A 503 ALA LEU ALA ALA HIS GLN LEU ASP ALA LEU VAL ALA PRO SEQRES 33 A 503 THR THR GLY VAL ALA TRP PRO ILE ARG SER GLU GLY ASP SEQRES 34 A 503 ASP PHE PRO GLY GLU SER TYR SER ALA ALA ALA VAL ALA SEQRES 35 A 503 GLY TYR PRO SER LEU THR VAL PRO MET GLY GLN ILE ASP SEQRES 36 A 503 GLY LEU PRO VAL GLY LEU LEU PHE MET GLY THR ALA TRP SEQRES 37 A 503 SER GLU PRO LYS LEU ILE GLU MET ALA TYR ALA TYR GLU SEQRES 38 A 503 GLN ARG THR ARG ALA ARG ARG PRO PRO HIS PHE ASP THR SEQRES 39 A 503 ASP ALA LEU ILE ASP ALA GLY GLU PRO SEQRES 1 B 503 SER ARG ASN VAL PRO PHE PRO TYR ALA GLU THR ASP VAL SEQRES 2 B 503 ALA ASP LEU GLN ALA ARG MET THR ALA GLY GLU LEU ASP SEQRES 3 B 503 SER THR THR LEU THR GLN ALA TYR LEU GLN ARG ILE ALA SEQRES 4 B 503 ALA LEU ASP ARG THR GLY PRO ARG LEU ARG ALA VAL ILE SEQRES 5 B 503 GLU LEU ASN PRO ASP ALA LEU LYS GLU ALA ALA GLU ARG SEQRES 6 B 503 ASP ARG GLU ARG ARG ASP GLY ARG LEU ARG GLY PRO LEU SEQRES 7 B 503 HIS GLY ILE PRO LEU LEU LEU LYS ASP ASN ILE ASN ALA SEQRES 8 B 503 ALA PRO MET ALA THR SER ALA GLY SER LEU ALA LEU GLN SEQRES 9 B 503 GLY PHE ARG PRO ASP ASP ALA TYR LEU VAL ARG ARG LEU SEQRES 10 B 503 ARG ASP ALA GLY ALA VAL VAL LEU GLY LYS THR ASN LEU SEQRES 11 B 503 SER GLU TRP ALA ASN PHE ARG GLY ASN ASP SER ILE SER SEQRES 12 B 503 GLY TRP SER ALA ARG GLY GLY GLN THR ARG ASN PRO TYR SEQRES 13 B 503 ARG ILE SER HIS SER PRO CYS GLY SER SER SER GLY SER SEQRES 14 B 503 ALA VAL ALA VAL ALA ALA ASN LEU ALA SER VAL ALA ILE SEQRES 15 B 503 GLY THR GLU THR ASP GLY SER ILE VAL CYS PRO ALA ALA SEQRES 16 B 503 ILE ASN GLY VAL VAL GLY LEU LYS PRO THR VAL GLY LEU SEQRES 17 B 503 VAL SER ARG ASP GLY ILE ILE PRO ILE SER PHE SER GLN SEQRES 18 B 503 ASP THR ALA GLY PRO MET ALA ARG SER VAL ALA ASP ALA SEQRES 19 B 503 ALA ALA VAL LEU THR ALA ILE ALA GLY ARG ASP ASP ALA SEQRES 20 B 503 ASP PRO ALA THR ALA THR MET PRO GLY ARG ALA VAL TYR SEQRES 21 B 503 ASP TYR THR ALA ARG LEU ASP PRO GLN GLY LEU ARG GLY SEQRES 22 B 503 LYS ARG ILE GLY LEU LEU GLN THR PRO LEU LEU LYS TYR SEQRES 23 B 503 ARG GLY MET PRO PRO LEU ILE GLU GLN ALA ALA THR GLU SEQRES 24 B 503 LEU ARG ARG ALA GLY ALA VAL VAL VAL PRO VAL GLU LEU SEQRES 25 B 503 PRO ASN GLN GLY ALA TRP ALA GLU ALA GLU ARG THR LEU SEQRES 26 B 503 LEU LEU TYR GLU PHE LYS ALA GLY LEU GLU ARG TYR PHE SEQRES 27 B 503 ASN THR HIS ARG ALA PRO LEU ARG SER LEU ALA ASP LEU SEQRES 28 B 503 ILE ALA PHE ASN GLN ALA HIS SER LYS GLN GLU LEU GLY SEQRES 29 B 503 LEU PHE GLY GLN GLU LEU LEU VAL GLU ALA ASP ALA THR SEQRES 30 B 503 ALA GLY LEU ALA ASP PRO ALA TYR ILE ARG ALA ARG SER SEQRES 31 B 503 ASP ALA ARG ARG LEU ALA GLY PRO GLU GLY ILE ASP ALA SEQRES 32 B 503 ALA LEU ALA ALA HIS GLN LEU ASP ALA LEU VAL ALA PRO SEQRES 33 B 503 THR THR GLY VAL ALA TRP PRO ILE ARG SER GLU GLY ASP SEQRES 34 B 503 ASP PHE PRO GLY GLU SER TYR SER ALA ALA ALA VAL ALA SEQRES 35 B 503 GLY TYR PRO SER LEU THR VAL PRO MET GLY GLN ILE ASP SEQRES 36 B 503 GLY LEU PRO VAL GLY LEU LEU PHE MET GLY THR ALA TRP SEQRES 37 B 503 SER GLU PRO LYS LEU ILE GLU MET ALA TYR ALA TYR GLU SEQRES 38 B 503 GLN ARG THR ARG ALA ARG ARG PRO PRO HIS PHE ASP THR SEQRES 39 B 503 ASP ALA LEU ILE ASP ALA GLY GLU PRO SEQRES 1 C 4 PHE CSI LEU PHA SEQRES 1 D 4 PHE CSI LEU PHA MODRES 1M21 PHA C 4 PHE PHENYLALANINAL MODRES 1M21 PHA D 4 PHE PHENYLALANINAL HET CSI C 2 13 HET PHA C 4 11 HET CSI D 2 13 HET PHA D 4 11 HETNAM CSI AMINO-(2-IMINO-HEXAHYDRO-PYRIMIDIN-4-YL)-ACETIC ACID HETNAM PHA PHENYLALANINAL FORMUL 3 CSI 2(C7 H12 N4 O4) FORMUL 3 PHA 2(C9 H11 N O) FORMUL 5 HOH *431(H2 O) HELIX 1 1 ASP A 49 ALA A 59 1 11 HELIX 2 2 ASP A 63 ASP A 79 1 17 HELIX 3 3 ASP A 94 ASP A 108 1 15 HELIX 4 4 SER A 137 GLN A 141 5 5 HELIX 5 5 ALA A 148 ALA A 157 1 10 HELIX 6 6 SER A 168 PHE A 173 5 6 HELIX 7 7 SER A 203 ALA A 212 1 10 HELIX 8 8 ILE A 227 ASN A 234 1 8 HELIX 9 9 SER A 267 ALA A 279 1 13 HELIX 10 10 ASP A 285 MET A 291 5 7 HELIX 11 11 ASP A 298 LEU A 303 5 6 HELIX 12 12 THR A 318 TYR A 323 5 6 HELIX 13 13 GLY A 325 ALA A 340 1 16 HELIX 14 14 TRP A 355 HIS A 378 1 24 HELIX 15 15 SER A 384 HIS A 395 1 12 HELIX 16 16 HIS A 395 LEU A 400 1 6 HELIX 17 17 GLN A 405 ALA A 413 1 9 HELIX 18 18 ASP A 419 GLY A 434 1 16 HELIX 19 19 GLY A 437 HIS A 445 1 9 HELIX 20 20 TYR A 473 GLY A 480 1 8 HELIX 21 21 SER A 506 ARG A 522 1 17 HELIX 22 22 ASP B 49 ALA B 59 1 11 HELIX 23 23 ASP B 63 ASP B 79 1 17 HELIX 24 24 ASP B 94 ASP B 108 1 15 HELIX 25 25 SER B 137 GLN B 141 5 5 HELIX 26 26 ALA B 148 ALA B 157 1 10 HELIX 27 27 SER B 168 PHE B 173 5 6 HELIX 28 28 SER B 203 ALA B 212 1 10 HELIX 29 29 ILE B 227 ASN B 234 1 8 HELIX 30 30 SER B 267 ALA B 279 1 13 HELIX 31 31 ASP B 285 MET B 291 5 7 HELIX 32 32 ASP B 298 LEU B 303 5 6 HELIX 33 33 THR B 318 TYR B 323 5 6 HELIX 34 34 GLY B 325 ALA B 340 1 16 HELIX 35 35 TRP B 355 HIS B 378 1 24 HELIX 36 36 SER B 384 HIS B 395 1 12 HELIX 37 37 HIS B 395 LEU B 400 1 6 HELIX 38 38 GLN B 405 ALA B 413 1 9 HELIX 39 39 ASP B 419 GLY B 434 1 16 HELIX 40 40 GLY B 437 HIS B 445 1 9 HELIX 41 41 TYR B 473 GLY B 480 1 8 HELIX 42 42 SER B 506 ARG B 522 1 17 SHEET 1 A11 VAL A 88 LEU A 91 0 SHEET 2 A11 VAL A 160 THR A 165 -1 O LYS A 164 N GLU A 90 SHEET 3 A11 PRO A 119 LYS A 123 1 N LEU A 120 O LEU A 162 SHEET 4 A11 VAL A 217 GLU A 222 1 O ILE A 219 N LEU A 121 SHEET 5 A11 THR A 260 ALA A 265 -1 O GLY A 262 N GLY A 220 SHEET 6 A11 VAL A 237 LYS A 240 -1 N VAL A 237 O ALA A 265 SHEET 7 A11 SER A 483 ILE A 491 -1 O SER A 483 N LYS A 240 SHEET 8 A11 LEU A 494 MET A 501 -1 O LEU A 498 N VAL A 486 SHEET 9 A11 ALA A 449 PRO A 453 -1 N ALA A 452 O LEU A 499 SHEET 10 A11 ARG A 312 LEU A 316 1 N GLY A 314 O VAL A 451 SHEET 11 A11 VAL A 343 VAL A 347 1 O VAL A 343 N ILE A 313 SHEET 1 B 2 TRP A 182 SER A 183 0 SHEET 2 B 2 GLY A 187 GLN A 188 -1 O GLY A 187 N SER A 183 SHEET 1 C11 VAL B 88 LEU B 91 0 SHEET 2 C11 VAL B 160 THR B 165 -1 O LYS B 164 N GLU B 90 SHEET 3 C11 PRO B 119 LYS B 123 1 N LEU B 120 O VAL B 160 SHEET 4 C11 VAL B 217 GLU B 222 1 O ILE B 219 N LEU B 121 SHEET 5 C11 THR B 260 ALA B 265 -1 O GLY B 262 N GLY B 220 SHEET 6 C11 VAL B 237 LYS B 240 -1 N VAL B 237 O ALA B 265 SHEET 7 C11 SER B 483 ILE B 491 -1 O SER B 483 N LYS B 240 SHEET 8 C11 LEU B 494 MET B 501 -1 O LEU B 498 N VAL B 486 SHEET 9 C11 ALA B 449 PRO B 453 -1 N ALA B 452 O LEU B 499 SHEET 10 C11 ARG B 312 LEU B 316 1 N GLY B 314 O VAL B 451 SHEET 11 C11 VAL B 343 VAL B 347 1 O VAL B 343 N ILE B 313 SHEET 1 D 2 TRP B 182 SER B 183 0 SHEET 2 D 2 GLY B 187 GLN B 188 -1 O GLY B 187 N SER B 183 LINK N PHE C 1 C7 CSI C 2 1555 1555 1.33 LINK C CSI C 2 N LEU C 3 1555 1555 1.32 LINK C LEU C 3 N PHA C 4 1555 1555 1.36 LINK N PHE D 1 C7 CSI D 2 1555 1555 1.33 LINK C CSI D 2 N LEU D 3 1555 1555 1.31 LINK C LEU D 3 N PHA D 4 1555 1555 1.36 CISPEP 1 ALA A 129 PRO A 130 0 0.16 CISPEP 2 GLY A 201 SER A 202 0 26.64 CISPEP 3 ALA B 129 PRO B 130 0 0.01 SITE 1 AC1 18 ALA A 171 ASN A 172 PHE A 173 SER A 180 SITE 2 AC1 18 CYS A 200 GLY A 201 SER A 202 ASP A 224 SITE 3 AC1 18 SER A 226 CYS A 229 ILE A 254 ARG A 360 SITE 4 AC1 18 LEU A 363 LEU A 407 PHE A 468 TYR A 473 SITE 5 AC1 18 HOH A 902 HOH A 933 SITE 1 AC2 17 ALA B 171 ASN B 172 PHE B 173 SER B 180 SITE 2 AC2 17 CYS B 200 GLY B 201 SER B 202 ASP B 224 SITE 3 AC2 17 SER B 226 CYS B 229 ILE B 254 ARG B 360 SITE 4 AC2 17 LEU B 363 LEU B 407 PHE B 468 TYR B 473 SITE 5 AC2 17 HOH B1937 CRYST1 74.598 62.559 102.382 90.00 90.00 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013405 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015985 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009767 0.00000